News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Tamara Bavendam, MD

Articles by Tamara Bavendam, MD

Challenges for Managing Overactive Bladder and Guidance for Patient Support

ByVernon F. Schabert, PhD,Tamara Bavendam, MD,Erica L. Goldberg,Jeffrey N. Trocio, MPH,Linda Brubaker, MD

March 24th 2009

Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults

ByRichard G. Roberts, MD, JD,Alan D. Garely, MD,Tamara Bavendam, MD

July 15th 2005

Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost Estimates

ByNicole M. Nitz, PhD,Zhanna Jumadilova, MD, MBA,Theodore Darkow, PharmD,Jennifer R. Frytak, PhD,Tamara Bavendam, MD

July 15th 2005

Latest Updated Articles

Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults
Published: July 15th 2005 | Updated:
Medical Costs After Initiation of Drug Treatment for Overactive Bladder: Effects of Selection Bias on Cost Estimates
Published: July 15th 2005 | Updated:
Challenges for Managing Overactive Bladder and Guidance for Patient Support
Published: March 24th 2009 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

Top 5 Most-Read Mental Health Content of 2025

Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy

Real-World Data Highlight Favorable Responses to Liso-Cel for R/R CLL

Top 5 Most-Read Heart Failure Content of 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.